Yeztugo

Active Ingredient(s): Lenacapavir
FDA Approved: * June 18, 2025
Pharm Company: * GILEAD SCIENCES INC
Category: HIV / AIDS
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Yeztugo 300 mg Oral Tablet, Film Coated
NDC: 61958-3401
Labeler:
Gilead Sciences, Inc.
YeztugoYeztugo Kit
NDC: 61958-3402
Labeler:
Gilead Sciences, Inc.

Related Brands

Drugs with the same active ingredients